60.70
Centene Corp stock is traded at $60.70, with a volume of 5.76M.
It is down -2.07% in the last 24 hours and up +2.46% over the past month.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.
See More
Previous Close:
$61.98
Open:
$58.7
24h Volume:
5.76M
Relative Volume:
1.30
Market Cap:
$31.26B
Revenue:
$163.07B
Net Income/Loss:
$3.31B
P/E Ratio:
9.7276
EPS:
6.24
Net Cash Flow:
$-490.00M
1W Performance:
-2.71%
1M Performance:
+2.46%
6M Performance:
-3.65%
1Y Performance:
-15.69%
Centene Corp Stock (CNC) Company Profile
Name
Centene Corp
Sector
Industry
Phone
(314) 725-4477
Address
7700 FORSYTH BLVD., ST LOUIS
Compare CNC with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
CNC
Centene Corp
|
60.70 | 31.26B | 163.07B | 3.31B | -490.00M | 6.24 |
![]()
UNH
Unitedhealth Group Inc
|
454.11 | 536.99B | 400.28B | 14.41B | 20.71B | 15.50 |
![]()
ELV
Elevance Health Inc
|
424.53 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
![]()
CI
Cigna Group
|
330.13 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
![]()
CVS
Cvs Health Corp
|
67.29 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
![]()
HUM
Humana Inc
|
264.48 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Centene Corp Stock (CNC) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Apr-08-25 | Upgrade | Jefferies | Underperform → Hold |
Feb-06-25 | Downgrade | Argus | Buy → Hold |
Dec-17-24 | Resumed | JP Morgan | Overweight |
Dec-13-24 | Upgrade | UBS | Neutral → Buy |
Dec-10-24 | Downgrade | Jefferies | Hold → Underperform |
Jul-24-24 | Downgrade | Jefferies | Buy → Hold |
May-30-24 | Initiated | Robert W. Baird | Neutral |
Mar-21-24 | Downgrade | Stephens | Overweight → Equal-Weight |
Mar-06-24 | Initiated | Barclays | Overweight |
Jan-02-24 | Upgrade | Wells Fargo | Equal Weight → Overweight |
Sep-05-23 | Upgrade | BofA Securities | Underperform → Neutral |
Aug-30-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
Jul-12-23 | Downgrade | Wolfe Research | Outperform → Peer Perform |
Jun-20-23 | Initiated | UBS | Neutral |
Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
Mar-08-23 | Downgrade | Deutsche Bank | Buy → Hold |
Feb-23-23 | Downgrade | JP Morgan | Overweight → Neutral |
Dec-13-22 | Downgrade | BofA Securities | Neutral → Underperform |
Sep-30-22 | Initiated | Argus | Buy |
Aug-26-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
Jul-28-22 | Resumed | Barclays | Overweight |
Jul-14-22 | Upgrade | Jefferies | Hold → Buy |
Jun-21-22 | Upgrade | Credit Suisse | Neutral → Outperform |
Jun-17-22 | Initiated | Loop Capital | Buy |
May-27-22 | Resumed | Bernstein | Outperform |
May-26-22 | Downgrade | BofA Securities | Buy → Neutral |
Jan-07-22 | Resumed | Barclays | Overweight |
Jan-06-22 | Resumed | JP Morgan | Overweight |
Dec-14-21 | Initiated | Goldman | Neutral |
Dec-13-21 | Reiterated | BMO Capital Markets | Outperform |
Dec-13-21 | Reiterated | BofA Securities | Buy |
Dec-13-21 | Reiterated | Credit Suisse | Neutral |
Dec-13-21 | Reiterated | Mizuho | Neutral |
Dec-13-21 | Reiterated | Oppenheimer | Outperform |
Dec-13-21 | Reiterated | Stephens | Overweight |
Dec-13-21 | Reiterated | Truist | Buy |
Dec-13-21 | Reiterated | Wells Fargo | Overweight |
Dec-13-21 | Reiterated | Wolfe Research | Outperform |
Nov-01-21 | Downgrade | Citigroup | Buy → Neutral |
Sep-10-21 | Initiated | Cowen | Outperform |
Jul-09-21 | Initiated | Seaport Global Securities | Buy |
May-19-21 | Initiated | Wells Fargo | Overweight |
May-11-21 | Upgrade | Stephens | Equal-Weight → Overweight |
Mar-10-21 | Initiated | Mizuho | Neutral |
Jan-21-21 | Resumed | Goldman | Neutral |
Jan-15-21 | Downgrade | Jefferies | Buy → Hold |
Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
Jul-01-20 | Initiated | SVB Leerink | Outperform |
Feb-05-20 | Upgrade | JP Morgan | Neutral → Overweight |
Feb-03-20 | Resumed | Evercore ISI | Outperform |
Jan-28-20 | Reiterated | Bernstein | Outperform |
Jan-06-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
Sep-12-19 | Initiated | Deutsche Bank | Buy |
May-10-19 | Upgrade | Citigroup | Neutral → Buy |
Jan-14-19 | Initiated | Stephens | Overweight |
Oct-24-18 | Upgrade | Leerink Partners | Mkt Perform → Outperform |
Jul-18-18 | Resumed | Citigroup | Neutral |
Dec-18-17 | Reiterated | Jefferies | Buy |
Sep-13-17 | Reiterated | Leerink Partners | Mkt Perform |
Jun-07-17 | Initiated | Morgan Stanley | Overweight |
May-22-17 | Downgrade | JP Morgan | Overweight → Neutral |
Apr-05-17 | Initiated | Deutsche Bank | Buy |
Mar-23-17 | Downgrade | Citigroup | Buy → Neutral |
Feb-08-17 | Reiterated | Barclays | Overweight |
Feb-07-17 | Resumed | Cantor Fitzgerald | Overweight |
Jan-04-17 | Initiated | Piper Jaffray | Overweight |
View All
Centene Corp Stock (CNC) Latest News
Jim Cramer Still Backs Centene Corporation (CNC): “I’ve Been a Fan Since Neidorff Days!” - Yahoo Finance
Health Net and Centene Foundation Commit $1 Million to Rebuild Los Angeles After Historic Fire Devastation - Financial Times
Lobbying Update: $105,000 of CENTENE CORPORATION lobbying was just disclosed - Quiver Quantitative
Here's How Much $1000 Invested In Centene 20 Years Ago Would Be Worth Today - Benzinga
Baird Adjusts Centene Price Target to $69 From $71, Maintains Neutral Rating - marketscreener.com
Baird Adjusts Price Target for Centene (CNC) Amid Policy Uncerta - GuruFocus
What To Expect From Centene's Q1 2025 Earnings Report - Barchart.com
Is Centene Corporation (CNC) the Top Healthcare Stock to Buy According to Billionaire David Einhorn? - Insider Monkey
Centene (CNC) Secures Medicaid Managed Care Contract Extension i - GuruFocus
Centene (CNC) Subsidiary Wins Key Nevada Medicaid Managed Care C - GuruFocus
Centene Extends SilverSummit's Presence to the Edges of Nevada - Yahoo Finance
CENTENE SUBSIDIARY SILVERSUMMIT HEALTHPLAN AWARDED NEVADA MEDICA - GuruFocus
Centene Subsidiary Silversummit Healthplan Awarded Nevada Medicaid Contract - marketscreener.com
CENTENE SUBSIDIARY SILVERSUMMIT HEALTHPLAN AWARDED NEVADA MEDICAID CONTRACT - PR Newswire
Guggenheim Initiates Coverage of Centene (BIT:1CNC) with Neutral Recommendation - Nasdaq
Health Net and Centene Foundation Invest More than $9 Million in Initiatives to Expand and Strengthen California's Physician Workforce – Company AnnouncementFT.com - Financial Times
Health care giant Centene writes a $10M check to Hope Florida Foundation - Florida Phoenix
Jefferies Upgrades Centene (BIT:1CNC) - Nasdaq
Guggenheim starts Centene stock coverage with neutral rating By Investing.com - Investing.com South Africa
Guggenheim Initiates Centene at Neutral - MarketScreener
Zacks.com featured highlights Cleveland-Cliff, Peabody, CVR Energy, Delek US and Centene - Yahoo Finance
Centene (CNC) Stock Surges Amid Strategic Shift and Industry Tre - GuruFocus
Jefferies Upgrades Centene (CNC) - MSN
Health insurance stocks soar after boost to Medicare reimbursement rates - Reuters
Centene Shares Rise After Jefferies Upgrade - MarketScreener
Cantor Fitzgerald maintains Overweight on Centene, $90 target - Investing.com
Cantor Fitzgerald maintains Overweight on Centene, $90 target By Investing.com - Investing.com UK
This Centene Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday - Benzinga
Jefferies Upgrades Centene to Hold From Underperform, Adjusts Price Target to $64 From $53 - MarketScreener
Health Insurers Rejoice With Medicare Rate Hike For 2026 - Finimize
Health insurance stocks rise on 'best case scenario' Medicare payment rates - MarketScreener
Jefferies lifts Centene stock rating, raises price target to $64 - Investing.com
Centene Corporation (CNC) Stock Forecasts - Yahoo Finance
Centene's Moat Downgraded on Uncertainty Over Government-Sponsored Health Plans - Morningstar
The Zacks Analyst Blog Highlights Lamb Weston, Centene, The Kroger, First Solar and American Water Works - Yahoo Finance
Strength Seen in Centene (CNC): Can Its 5.9% Jump Turn into More Strength? - Nasdaq
Cantor Fitzgerald maintains Overweight on Centene shares, $90 target By Investing.com - Investing.com South Africa
Will Centene (CNC) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Zacks Industry Outlook Highlights UnitedHealth, Humana and Centene - Zacks Investment Research
Cantor Fitzgerald maintains Overweight on Centene shares, $90 target - Investing.com
Here are the stocks rising and falling the most after Trump’s tariffs - The Hill
Centene Co. (NYSE:CNC) Shares Purchased by Mitsubishi UFJ Asset Management Co. Ltd. - MarketBeat
Korea Investment CORP Has $19.09 Million Stock Holdings in Centene Co. (NYSE:CNC) - MarketBeat
Centene Corporation (CNC) Slid Despite Strong Fundamentals - Yahoo Finance
Texas AG investigating Centene subsidiary Superior HealthPlan for alleged spying - The Business Journals
Texas probes Superior HealthPlan allegations of hiring private investigators - Insurance Business America
Centene & HMHB Hawaii Expand Partnership for Maternal Care - MSN
'Ohana Health Plan and Healthy Mothers Healthy Babies Coalition of Hawaii Extend Partnership to Improve Maternal and Child Health Outcomes - Quantisnow
Health care CEO fired after Texas House hearing - Dallas News
2 Reasons to Like CNC and 1 to Stay Skeptical - Yahoo Finance
Centene Corp Stock (CNC) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):